National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Tohutoru Kātū Chicago (17th ed.)National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, me Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
Tohutoro MLA (9th ed.)National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, me Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.